Thu, Jul 24, 2014, 4:45 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Endocyte, Inc. (ECYT) Message Board

  • dkenigsberg dkenigsberg Feb 13, 2013 1:23 PM Flag

    Leerink Swann Conference

    ECYT is vastly underappreciated in the market place. It's platform has so many applications in areas with large populations that badly need a new approach to their medical ailments. Including over 50% of cancers which over express folate to inflammatory disease and even polycysticn renal disease which often leads to renal failure. At the conference today the CFO indicated this new area of personal medicine was so widely misunderstood that it represented its greatest impediment to the appreciation of the market for this company. Here a company has the greatest platforms that I am aware of for a new approach to medical therapeutics and routinely trades less then 100k shares and is valued less then 100 million when you consider the cash it has.
    I am an MD and biotech investor and this is the best investment opportunity I have ever seen.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ECYT
6.31+0.07(+1.12%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.